Lexeo Therapeutics
Develops genetic medicines for cardiovascular and neurodegenerative diseases.
Company facts
- Founded
- 2017
- Employees
- 85
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: LXEO
Develops genetic medicines for cardiovascular and neurodegenerative diseases.
Company facts